Congress orders audit of nation's opioid treatment capacity
H.R. 9676 — Examining Opioid Treatment Infrastructure Act of 2026 · Filed by Bill Foster (D-IL) · Introduced Jul 14, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Government Accountability Office (GAO) to study and report on the nation's capacity to treat opioid addiction—how many inpatient and outpatient treatment beds exist, where they are located, whether they use evidence-based methods, and what gaps remain. The report must cover treatment for pregnant women, adolescents, and Native Americans, and identify barriers to sharing overdose data across agencies.
Why we flagged it
The bill's sole operative mechanism is a directive to the GAO to conduct a comprehensive study and report on opioid treatment infrastructure. It creates no new programs, funding, or regulatory authority—only a fact-finding and reporting obligation in service of evidence-based policymaking.
What the text implies
- Report findings may expose significant regional disparities in treatment access, potentially creating political pressure for federal funding reallocation or new grant programs.
- Inclusion of barriers to real-time overdose data sharing may reveal systemic interagency coordination failures, suggesting need for data-governance reform.
- Study of treatment capacity for pregnant women and adolescents may highlight gaps in specialized services, informing future maternal health and pediatric addiction policy.
- Assessment of Native American access through Indian health programs may document systemic underservice, potentially triggering tribal consultation and funding discussions.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Citizens gain transparency and evidence-based policy guidance on a critical public health crisis. The study creates a factual baseline for treatment capacity and identifies barriers to care, enabling Congress to make informed decisions about funding and policy. No restrictions on citizens' rights or access are imposed.
Named in the bill
Comptroller General of the United States, Government Accountability Office (GAO), Congress, Food and Drug Administration (FDA), Indian Health Care Improvement Act, American Indians and Alaska Natives
Where it stands
- Jul 14, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jul 14, 2026 — Referred to House Committee on Natural Resources and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $710,000 in lobbying spend. A filing names 24 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Bill Foster, the sponsor, reported $894,500 in PAC receipts in the 2026 cycle.
- American Forest & Paper Association — $710,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,937 characters) on Jul 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress orders audit of nation's opioid treatment capacity” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9676 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.